Annual CFF
$32.17 M
+$31.95 M+14723.04%
December 31, 2023
Summary
- As of February 8, 2025, APYX annual cash flow from financing activities is $32.17 million, with the most recent change of +$31.95 million (+14723.04%) on December 31, 2023.
- During the last 3 years, APYX annual CFF has risen by +$32.24 million (+44163.01%).
- APYX annual CFF is now at all-time high.
Performance
APYX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$5000.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, APYX quarterly cash flow from financing activities is -$5000.00, unchanged on September 30, 2024.
- Over the past year, APYX quarterly CFF has stayed the same.
- APYX quarterly CFF is now -100.02% below its all-time high of $23.84 million, reached on December 31, 2023.
Performance
APYX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$23.83 M
-$169.00 K-0.70%
September 30, 2024
Summary
- As of February 8, 2025, APYX TTM cash flow from financing activities is $23.83 million, with the most recent change of -$169.00 thousand (-0.70%) on September 30, 2024.
- Over the past year, APYX TTM CFF has dropped by -$220.00 thousand (-0.91%).
- APYX TTM CFF is now -25.92% below its all-time high of $32.17 million, reached on December 31, 2023.
Performance
APYX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
APYX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | 0.0% | -0.9% |
| 3 y3 years | +10000.0% | +84.8% | +10000.0% |
| 5 y5 years | +1390.8% | -113.5% | +10000.0% |
APYX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -100.0% | +87.2% | -25.9% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -100.0% | +96.3% | -25.9% | >+9999.0% |
| alltime | all time | at high | +1390.8% | -100.0% | +99.8% | -25.9% | +986.2% |
Apyx Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5000.00(0.0%) | $23.83 M(-0.7%) |
| Jun 2024 | - | -$5000.00(0.0%) | $24.00 M(-0.2%) |
| Mar 2024 | - | -$5000.00(-100.0%) | $24.05 M(-25.2%) |
| Dec 2023 | $32.17 M(>+9900.0%) | $23.84 M(>+9900.0%) | $32.17 M(+287.0%) |
| Sep 2023 | - | $164.00 K(+256.5%) | $8.31 M(+0.4%) |
| Jun 2023 | - | $46.00 K(-99.4%) | $8.28 M(+0.5%) |
| Mar 2023 | - | $8.11 M(<-9900.0%) | $8.23 M(+3693.1%) |
| Dec 2022 | $217.00 K(+804.2%) | -$10.00 K(-107.9%) | $217.00 K(+15.4%) |
| Sep 2022 | - | $127.00 K(+6250.0%) | $188.00 K(+571.4%) |
| Jun 2022 | - | $2000.00(-98.0%) | $28.00 K(-84.7%) |
| Mar 2022 | - | $98.00 K(-351.3%) | $183.00 K(+662.5%) |
| Dec 2021 | $24.00 K(-132.9%) | -$39.00 K(+18.2%) | $24.00 K(-133.8%) |
| Sep 2021 | - | -$33.00 K(-121.0%) | -$71.00 K(-200.0%) |
| Jun 2021 | - | $157.00 K(-357.4%) | $71.00 K(-147.7%) |
| Mar 2021 | - | -$61.00 K(-54.5%) | -$149.00 K(+104.1%) |
| Dec 2020 | -$73.00 K(-149.7%) | -$134.00 K(-222.9%) | -$73.00 K(-230.4%) |
| Sep 2020 | - | $109.00 K(-273.0%) | $56.00 K(-450.0%) |
| Jun 2020 | - | -$63.00 K(-520.0%) | -$16.00 K(-116.8%) |
| Mar 2020 | - | $15.00 K(-400.0%) | $95.00 K(-35.4%) |
| Dec 2019 | $147.00 K(-105.9%) | -$5000.00(-113.5%) | $147.00 K(-49.1%) |
| Sep 2019 | - | $37.00 K(-22.9%) | $289.00 K(-112.8%) |
| Jun 2019 | - | $48.00 K(-28.4%) | -$2.26 M(-4.6%) |
| Mar 2019 | - | $67.00 K(-51.1%) | -$2.37 M(-5.1%) |
| Dec 2018 | -$2.49 M(+942.7%) | $137.00 K(-105.5%) | -$2.49 M(-7.3%) |
| Sep 2018 | - | -$2.51 M(+4081.7%) | -$2.69 M(+1020.4%) |
| Jun 2018 | - | -$60.00 K(0.0%) | -$240.00 K(0.0%) |
| Mar 2018 | - | -$60.00 K(0.0%) | -$240.00 K(+0.4%) |
| Dec 2017 | -$239.00 K(-104.2%) | -$60.00 K(0.0%) | -$239.00 K(-104.3%) |
| Sep 2017 | - | -$60.00 K(0.0%) | $5.54 M(-2.1%) |
| Jun 2017 | - | -$60.00 K(+1.7%) | $5.66 M(-1.1%) |
| Mar 2017 | - | -$59.00 K(-101.0%) | $5.72 M(+0.0%) |
| Dec 2016 | $5.71 M(-55.3%) | $5.71 M(+9586.4%) | $5.71 M(-9623.3%) |
| Sep 2016 | - | $59.00 K(+5800.0%) | -$60.00 K(-72.5%) |
| Jun 2016 | - | $1000.00(-101.6%) | -$218.00 K(-121.6%) |
| Mar 2016 | - | -$61.00 K(+3.4%) | $1.01 M(-92.1%) |
| Dec 2015 | $12.78 M(-1217.0%) | -$59.00 K(-40.4%) | $12.78 M(+1.8%) |
| Sep 2015 | - | -$99.00 K(-108.1%) | $12.55 M(-0.9%) |
| Jun 2015 | - | $1.23 M(-89.5%) | $12.66 M(+18.9%) |
| Mar 2015 | - | $11.71 M(-4151.2%) | $10.65 M(-1030.9%) |
| Dec 2014 | -$1.14 M(-116.6%) | -$289.00 K(-1800.0%) | -$1.14 M(-118.8%) |
| Sep 2014 | - | $17.00 K(-102.2%) | $6.09 M(+0.5%) |
| Jun 2014 | - | -$786.00 K(+814.0%) | $6.06 M(-11.1%) |
| Mar 2014 | - | -$86.00 K(-101.2%) | $6.82 M(-1.0%) |
| Dec 2013 | $6.89 M(-5396.9%) | $6.94 M(<-9900.0%) | $6.89 M(-7925.0%) |
| Sep 2013 | - | -$11.00 K(-60.7%) | -$88.00 K(-20.0%) |
| Jun 2013 | - | -$28.00 K(+75.0%) | -$110.00 K(-3.5%) |
| Mar 2013 | - | -$16.00 K(-51.5%) | -$114.00 K(-12.3%) |
| Dec 2012 | -$130.00 K(-57.0%) | -$33.00 K(0.0%) | -$130.00 K(-55.8%) |
| Sep 2012 | - | -$33.00 K(+3.1%) | -$294.00 K(-1.0%) |
| Jun 2012 | - | -$32.00 K(0.0%) | -$297.00 K(-0.7%) |
| Mar 2012 | - | -$32.00 K(-83.8%) | -$299.00 K(-1.0%) |
| Dec 2011 | -$302.00 K | -$197.00 K(+447.2%) | -$302.00 K(+118.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$36.00 K(+5.9%) | -$138.00 K(+2.2%) |
| Jun 2011 | - | -$34.00 K(-2.9%) | -$135.00 K(-108.3%) |
| Mar 2011 | - | -$35.00 K(+6.1%) | $1.63 M(-2.7%) |
| Dec 2010 | $1.68 M(-22.1%) | -$33.00 K(0.0%) | $1.68 M(+3.0%) |
| Sep 2010 | - | -$33.00 K(-101.9%) | $1.63 M(-4.3%) |
| Jun 2010 | - | $1.73 M(>+9900.0%) | $1.70 M(-0.1%) |
| Mar 2010 | - | $11.00 K(-113.5%) | $1.70 M(-20.9%) |
| Dec 2009 | $2.15 M(-25.4%) | -$81.50 K(-306.9%) | $2.15 M(+4.9%) |
| Sep 2009 | - | $39.40 K(-97.7%) | $2.05 M(-57.8%) |
| Jun 2009 | - | $1.73 M(+276.5%) | $4.86 M(+45.6%) |
| Mar 2009 | - | $460.70 K(-352.4%) | $3.34 M(+15.7%) |
| Dec 2008 | $2.89 M(+1316.3%) | -$182.50 K(-106.4%) | $2.89 M(-5.6%) |
| Sep 2008 | - | $2.85 M(+1246.6%) | $3.06 M(+1223.3%) |
| Jun 2008 | - | $211.80 K(+3158.5%) | $231.10 K(+250.2%) |
| Mar 2008 | - | $6500.00(-152.8%) | $66.00 K(-67.6%) |
| Dec 2007 | $203.90 K(-82.2%) | -$12.30 K(-149.0%) | $203.90 K(-81.5%) |
| Sep 2007 | - | $25.10 K(-46.3%) | $1.10 M(-11.0%) |
| Jun 2007 | - | $46.70 K(-67.7%) | $1.24 M(+8.6%) |
| Mar 2007 | - | $144.40 K(-83.7%) | $1.14 M(-0.3%) |
| Dec 2006 | $1.15 M(+969.4%) | $887.40 K(+447.4%) | $1.15 M(+237.6%) |
| Sep 2006 | - | $162.10 K(-417.2%) | $339.60 K(+78.0%) |
| Jun 2006 | - | -$51.10 K(-134.5%) | $190.80 K(-21.5%) |
| Mar 2006 | - | $148.00 K(+83.6%) | $243.00 K(+126.7%) |
| Dec 2005 | $107.20 K(-58.7%) | $80.60 K(+506.0%) | $107.20 K(+348.5%) |
| Sep 2005 | - | $13.30 K(+1109.1%) | $23.90 K(-35.4%) |
| Jun 2005 | - | $1100.00(-91.0%) | $37.00 K(-77.2%) |
| Mar 2005 | - | $12.20 K(-551.9%) | $162.10 K(-37.5%) |
| Dec 2004 | $259.40 K(-177.8%) | -$2700.00(-110.2%) | $259.30 K(-30.1%) |
| Sep 2004 | - | $26.40 K(-79.1%) | $370.90 K(+165.5%) |
| Jun 2004 | - | $126.20 K(+15.4%) | $139.70 K(-137.5%) |
| Mar 2004 | - | $109.40 K(+0.5%) | -$372.30 K(+11.6%) |
| Dec 2003 | -$333.50 K(+1182.7%) | $108.90 K(-153.2%) | -$333.50 K(-56.2%) |
| Sep 2003 | - | -$204.80 K(-46.9%) | -$762.00 K(+63.3%) |
| Jun 2003 | - | -$385.80 K(-360.3%) | -$466.50 K(-1302.3%) |
| Mar 2003 | - | $148.20 K(-146.4%) | $38.80 K(-249.8%) |
| Dec 2002 | -$26.00 K(-78.7%) | -$319.60 K(-452.4%) | -$25.90 K(-134.8%) |
| Sep 2002 | - | $90.70 K(-24.1%) | $74.40 K(-175.2%) |
| Jun 2002 | - | $119.50 K(+43.1%) | -$98.90 K(<-9900.0%) |
| Mar 2002 | - | $83.50 K(-138.1%) | $900.00(-100.7%) |
| Dec 2001 | -$121.80 K(-20.9%) | -$219.30 K(+165.5%) | -$121.80 K(-1002.2%) |
| Sep 2001 | - | -$82.60 K(-137.7%) | $13.50 K(-200.0%) |
| Jun 2001 | - | $219.30 K(-659.4%) | -$13.50 K(-92.5%) |
| Mar 2001 | - | -$39.20 K(-53.3%) | -$180.60 K(+17.2%) |
| Dec 2000 | -$154.00 K(-42.5%) | -$84.00 K(-23.4%) | -$154.10 K(+119.8%) |
| Sep 2000 | - | -$109.60 K(-310.0%) | -$70.10 K(-277.5%) |
| Jun 2000 | - | $52.20 K(-511.0%) | $39.50 K(-411.0%) |
| Mar 2000 | - | -$12.70 K | -$12.70 K |
| Dec 1999 | -$267.60 K(-138.9%) | - | - |
| Dec 1998 | $688.30 K(+142.4%) | - | - |
| Dec 1997 | $283.90 K(>+9900.0%) | - | - |
| Dec 1996 | $0.00(-100.0%) | - | - |
| Dec 1995 | -$16.30 K | - | - |
FAQ
- What is Apyx Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Apyx Medical?
- What is Apyx Medical annual CFF year-on-year change?
- What is Apyx Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Apyx Medical?
- What is Apyx Medical quarterly CFF year-on-year change?
- What is Apyx Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Apyx Medical?
- What is Apyx Medical TTM CFF year-on-year change?
What is Apyx Medical annual cash flow from financing activities?
The current annual CFF of APYX is $32.17 M
What is the all time high annual CFF for Apyx Medical?
Apyx Medical all-time high annual cash flow from financing activities is $32.17 M
What is Apyx Medical annual CFF year-on-year change?
Over the past year, APYX annual cash flow from financing activities has changed by +$31.95 M (+14723.04%)
What is Apyx Medical quarterly cash flow from financing activities?
The current quarterly CFF of APYX is -$5000.00
What is the all time high quarterly CFF for Apyx Medical?
Apyx Medical all-time high quarterly cash flow from financing activities is $23.84 M
What is Apyx Medical quarterly CFF year-on-year change?
Over the past year, APYX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Apyx Medical TTM cash flow from financing activities?
The current TTM CFF of APYX is $23.83 M
What is the all time high TTM CFF for Apyx Medical?
Apyx Medical all-time high TTM cash flow from financing activities is $32.17 M
What is Apyx Medical TTM CFF year-on-year change?
Over the past year, APYX TTM cash flow from financing activities has changed by -$220.00 K (-0.91%)